Kalvista Pharmaceuticals Inc (KALV.OQ)
KALV.OQ on NASDAQ Stock Exchange Global Market
8.86USD
25 Apr 2018
8.86USD
25 Apr 2018
Change (% chg)
-- (--)
-- (--)
Prev Close
$8.86
$8.86
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
11,127
11,127
52-wk High
$15.75
$15.75
52-wk Low
$5.48
$5.48
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Jan '18 | 2.33 | -0.485 |
| Oct | 1.13 | -0.498 | |
| Jul | 0.10 | -0.507 | |
| FY 2017 | Apr '17 | 0.11 | -0.440 |
| Jan '17 | 0.25 | -0.998 | |
| FY 2016 | Sep '16 | 0.01 | -1.268 |
| Jun '16 | 0.01 | -3.907 | |
| Mar '16 | 0.01 | -3.513 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jan-18 | 1 | 5.40 | 5.40 | 5.40 | -- |
| Quarter Ending Apr-18 | 1 | 5.00 | 5.00 | 5.00 | -- |
| Year Ending Apr-18 | 1 | 8.60 | 8.60 | 8.60 | -- |
| Year Ending Apr-19 | 1 | 14.40 | 14.40 | 14.40 | -- |
| Earnings (per share) | |||||
| Quarter Ending Jan-18 | 1 | -0.13 | -0.13 | -0.13 | -- |
| Quarter Ending Apr-18 | 1 | -0.26 | -0.26 | -0.26 | -- |
| Year Ending Apr-18 | 1 | -1.74 | -1.74 | -1.74 | -- |
| Year Ending Apr-19 | 1 | -1.59 | -1.59 | -1.59 | -- |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 29.65 | 32.31 | |
| P/E High - Last 5 Yrs. | -- | 40.53 | 46.12 | |
| P/E Low - Last 5 Yrs. | -- | 23.87 | 24.71 | |
| Beta | -- | 0.80 | 0.79 | |
| Price to Sales (TTM) | 27.05 | 4.37 | 7.14 | |
| Price to Book (MRQ) | 3.35 | 3.79 | 4.88 | |
| Price to Tangible Book (MRQ) | 3.47 | 4.69 | 6.49 | |
| Price to Cash Flow (TTM) | -- | 21.39 | 24.37 | |
| % Owned Institutions | 66.87 | 1.22 | 2.32 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 1.68 | 1.58 | |
| Dividend Yield - 5 Year Avg | -- | 0.76 | 0.78 | |
| Dividend 5 Year Growth Rate | -- | 2.85 | 4.08 | |
| Payout Ratio(TTM) | -- | 20.95 | 21.09 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 839.92 | 7.02 | 9.18 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 1,263.57 | 9.89 | 11.01 | |
| Sales - 5 Yr. Growth Rate | -- | 7.67 | 8.23 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 51.40 | 20.70 | 23.62 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 80.06 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 9.09 | 10.39 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 9.75 | 10.47 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.51 | 2.52 |
| Current Ratio (MRQ) | 2.73 | 3.57 | 3.58 |
| LT Debt to Equity (MRQ) | 0.41 | 8.89 | 11.61 |
| Total Debt to Equity (MRQ) | 1.19 | 11.22 | 14.31 |
| Interest Coverage (TTM) | -30.32 | 36.66 | 30.88 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 54.94 | 54.20 | |
| Gross Margin - 5 Yr. Avg. | -- | 52.32 | 52.34 | |
| EBITD Margin (TTM) | -563.85 | -- | -- | |
| EBITD - 5 Yr. Avg | -- | 18.46 | 15.90 | |
| Operating Margin (TTM) | -567.67 | 12.86 | 3.62 | |
| Operating Margin - 5 Yr. Avg. | -- | 14.17 | 11.17 | |
| Pre-Tax Margin (TTM) | -527.54 | 13.10 | 4.27 | |
| Pre-Tax Margin - 5 Yr. Avg. | -- | 14.53 | 11.48 | |
| Net Profit Margin (TTM) | -527.54 | 9.51 | 0.90 | |
| Net Profit Margin - 5 Yr. Avg. | -- | 10.85 | 7.81 | |
| Effective Tax Rate (TTM) | -- | 22.46 | 31.67 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 23.68 | 24.29 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | -- | 892,442,880 | 786,924,448 | |
| Net Income/Employee (TTM) | -- | 104,727,878 | 92,306,248 | |
| Receivable Turnover (TTM) | 0.89 | 5.53 | 5.48 | |
| Inventory Turnover (TTM) | -- | 2.53 | 3.46 | |
| Asset Turnover (TTM) | 0.07 | 0.90 | 0.87 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -36.96 | 10.76 | 10.35 | |
| Return on Assets - 5 Yr. Avg. | -- | 11.98 | 11.38 | |
| Return on Investment (TTM) | -49.99 | 13.36 | 12.97 | |
| Return on Investment - 5 Yr. Avg. | -- | 15.50 | 14.74 | |
| Return on Equity (TTM) | -61.02 | 15.09 | 14.84 | |
| Return on Equity - 5 Yr. Avg. | -- | 16.72 | 16.08 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -- | -- | -- |
| EPS (TTM) % | -- | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Kalvista Pharmaceuticals Inc
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 66.87% |
| # of Holders: | 32 |
| Total Shares Held: | 7,219,373 |
| 3 Mo. Net Change: | 371 |
| # New Positions: | 1 |
| # Closed Positions: | 1 |
| # Increased Positions: | 2 |
| # Reduced Positions: | 2 |
| # Net Buyers: | 0 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.